Research keywords (8):
endoscopic surgery
, oncology
, pancreatic cancer
, hepato-biliary-pancreatic cancer
, transrational research
, hepato-biliary-pancreatic surgery
, clinical oncology
, gastrointestinal surgery
Research theme for competitive and other funds (11):
2020 - 2023 A double-blinded RCT for investigating clinical efficacy of AHCC in patients with pancreatic ductal adenocarcinoma
2019 - 2022 Tumor-educated platelets of pancreatic cancer cases from the viewpoint of EMT status
Takamichi Igarashi, Suguru Yamada, Yui Hoshino, Kenta Murotani, Hayato Baba, Hideki Takami, Isaku Yoshioka, Kazuto Shibuya, Yasuhiro Kodera, Tsutomu Fujii. Prognostic factors in conversion surgery following nab-paclitaxel with gemcitabine and subsequent chemoradiotherapy for unresectable locally advanced pancreatic cancer: Results of a dual-center study. Annals of gastroenterological surgery. 2023. 7. 1. 157-166
Kota Nakamura, Zhongxu Zhu, Souvick Roy, Eunsung Jun, Haiyong Han, Ruben M Munoz, Satoshi Nishiwada, Geeta Sharma, Derek Cridebring, Frederic Zenhausern, et al. An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study. Gastroenterology. 2022. 163. 5. 1252-1266
Masaya Yamanaka, Masamichi Hayashi, Fuminori Sonohara, Suguru Yamada, Haruyoshi Tanaka, Akihiro Sakai, Shinji Mii, Daigo Kobayashi, Keisuke Kurimoto, Nobutake Tanaka, et al. ASO Visual Abstract: Downregulation of ROBO4 in Pancreatic Cancer Serves as a Biomarker of Poor Prognosis and Indicates Increased Cell Motility and Proliferation Through Activation of MMP-9. Annals of surgical oncology. 2022. 29. 11. 7192-7193
Masaya Yamanaka, Masamichi Hayashi, Fuminori Sonohara, Suguru Yamada, Haruyoshi Tanaka, Akihiro Sakai, Shinji Mii, Daigo Kobayashi, Keisuke Kurimoto, Nobutake Tanaka, et al. Downregulation of ROBO4 in Pancreatic Cancer Serves as a Biomarker of Poor Prognosis and Indicates Increased Cell Motility and Proliferation Through Activation of MMP-9. Annals of surgical oncology. 2022. 29. 11. 7180-7189
Suguru Yamada, Tsutomu Fujii, Sohei Satoi. Author's reply: Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis (Br J Surg 2020; 107: 1811-1817). The British journal of surgery. 2021. 108. 5. e212